BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35383811)

  • 1. Curcumin doped zeolitic imidazolate framework nanoplatforms as multifunctional nanocarriers for tumor chemo/immunotherapy.
    Liu J; Liu S; Wu Y; Xu X; Li Q; Yang M; Gong A; Zhang M; Lu R; Du F
    Biomater Sci; 2022 May; 10(9):2384-2393. PubMed ID: 35383811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-Step Synthesis of Nanoscale Zeolitic Imidazolate Frameworks with High Curcumin Loading for Treatment of Cervical Cancer.
    Zheng M; Liu S; Guan X; Xie Z
    ACS Appl Mater Interfaces; 2015 Oct; 7(40):22181-7. PubMed ID: 26403308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
    Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid coating on the surface of curcumin-loaded ZIF-8 nanoparticles for improved breast cancer therapy: An in vitro and in vivo study.
    Yu S; Wang S; Xie Z; Yu S; Li L; Xiao H; Song Y
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111759. PubMed ID: 33892283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of Polydopamine-Based Curcumin Nanoparticles for Chemical Stability and pH-Responsive Delivery.
    Pan H; Shen X; Tao W; Chen S; Ye X
    J Agric Food Chem; 2020 Mar; 68(9):2795-2802. PubMed ID: 32031786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
    Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
    Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
    Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
    ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pH-responsive alginate-stabilized curcumin-selenium-ZIF-8 nanocomposites for synergistic breast cancer therapy.
    Frouhar E; Adibifar A; Salimi M; Karami Z; Shadmani N; Rostamizadeh K
    J Drug Target; 2024 Apr; 32(4):444-455. PubMed ID: 38445558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese Dioxide Nanoplatform with a Hollow Rhombic Dodecahedron Morphology for Drug Delivery.
    Zhang Z; Yu D; Sui D; Shi M; Wang K; Zhang Y; Ji Y
    ACS Appl Bio Mater; 2024 Feb; 7(2):1169-1178. PubMed ID: 38253011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release.
    Zhang J; Li S; An FF; Liu J; Jin S; Zhang JC; Wang PC; Zhang X; Lee CS; Liang XJ
    Nanoscale; 2015 Aug; 7(32):13503-10. PubMed ID: 26199064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyacrylic acid@zeolitic imidazolate framework-8 nanoparticles with ultrahigh drug loading capability for pH-sensitive drug release.
    Ren H; Zhang L; An J; Wang T; Li L; Si X; He L; Wu X; Wang C; Su Z
    Chem Commun (Camb); 2014 Jan; 50(8):1000-2. PubMed ID: 24306285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic-Assisted ZIF-Silk-Polydopamine Nanoparticles as Promising Drug Carriers for Breast Cancer Therapy.
    Gao Z; Mansor MH; Winder N; Demiral S; Maclnnes J; Zhao X; Muthana M
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BSA Nanoparticles Modified with
    Zhang S; Asghar S; Yu F; Chen Z; Hu Z; Ping Q; Shao F; Xiao Y
    J Agric Food Chem; 2019 Aug; 67(33):9371-9381. PubMed ID: 31379162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells.
    Li J; Jiang F; Chi Z; Han D; Yu L; Liu C
    Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core-shell structured 5-FU@ZIF-90@ZnO as a biodegradable nanoplatform for synergistic cancer therapy.
    Xiao X; Liang S; Zhao Y; Huang D; Xing B; Cheng Z; Lin J
    Nanoscale; 2020 Feb; 12(6):3846-3854. PubMed ID: 31995084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
    Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
    Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.